Alternatives to AarogyaAI

An AI-driven solution for public health screening utilizing X-Ray and CT scans focuses on detecting chest abnormalities such as Tuberculosis and infections similar to COVID-19. This advanced technology enhances X-ray imaging for identifying patterns associated with infectious diseases like TB and COVID-19, allowing for immediate prescreening and triage. We have refined the entire workflow to ensure that imaging assessment, diagnosis, and reporting are carried out without any complications. A smart notification system alleviates the pressure involved in the reporting process. The solution boasts three primary features: classifying, localizing, and quantifying lesions. By harnessing the power of Artificial Intelligence, we are committed to delivering prompt and efficient teleradiology services to the worldwide imaging community, ultimately improving patient outcomes and streamlining healthcare delivery.

ClinCapture's mission is to create software that saves lives. ClinCapture's technology reduces the cost of clinical trials. It streamlines data capture and protects patient privacy. Clincapture is a platform that facilitates the evaluation and development drugs, biologics and devices that have the potential to treat a wide variety of medical conditions or diseases.

Pharmacists initiate a Comprehensive Medication Review at the start of programs to address issues related to medication nonadherence. Patients struggling to manage their diabetes face a significantly higher likelihood of severe complications, increased hospitalizations, and emergency room visits, which also leads to more costly associated health issues. Adhering to prescribed medications is crucial as it helps prevent the failure of transplanted organs, thereby avoiding challenging and costly complications like rejection episodes, infections, graft failure, and the need for retransplantation. emocha serves as the leading standard of care for numerous Tuberculosis programs nationwide. Additionally, emocha proves to be an effective resource for patients managing HIV and HCV medications. Furthermore, emocha aids employers and public health organizations across the nation by facilitating vaccination tracking, monitoring symptoms, conducting contact investigations and tracing, as well as providing a clinical triage service to ensure community safety and health. This multifaceted approach underscores the vital role of technology in enhancing patient care and public health initiatives.

A secure and top-tier prescription writing system ensures a reliable approach to managing patient medications. It conducts a thorough comparative analysis of a patient's medical history while checking for potential drug interactions and brand compatibility. This facility offers automatic safety checks for medications and allows users to search for appropriate drugs and brands effortlessly. Records from every patient visit are maintained in a chronological format, streamlining the process. Generating a new prescription can be accomplished in under two minutes, enhancing efficiency. The system scans a patient’s previous medical and familial history to provide valuable insights and recommendations. It also assesses drug safety concerning specific conditions, such as G6PD deficiency, porphyria, hypertension, and COPD, thus simplifying the workflow for both healthcare providers and patients. With comprehensive prescribing information for approximately 70,000 brands from Indian, British, and American pharmaceutical databases, users have access to a wealth of resources. Additionally, it includes complete monographs for nearly 3,000 generic drugs sourced from reputable references like the PDR of the U.S.A., Martindale’s pharmacology, and the British National Formulary, encompassing complete diagnostic details, differential diagnoses, and treatment protocols for a variety of conditions. This innovative system not only improves the quality of patient care but also enhances the overall management of healthcare practices.

An AI-driven solution utilizing X-Ray and CT scans is designed for public health screening, focusing on identifying chest pathologies such as Tuberculosis and COVID-19-related infections. This innovative system, known as Genki, integrates "AI+Expert in the loop" to deliver a comprehensive imaging workflow, where artificial intelligence enhances the capabilities of imaging specialists, resulting in quicker report generation and increased productivity. Utilizing cutting-edge technology, Genki effectively augments X-ray imaging for the analysis of infectious diseases like TB and COVID-19, offering rapid prescreening and triage capabilities. We have meticulously refined the entire workflow to facilitate a seamless process for imaging assessment, diagnosis, and reporting, while a smart notification system alleviates the stress often associated with reporting tasks. Key features of Genki include the ability to classify, localize, and quantify lesions effectively. The solution emphasizes point-of-care diagnostics, which is essential for addressing the gaps in disease elimination, and can be integrated into mobile X-ray units and CT scanners, ensuring immediate triage and prescreening when needed. This approach not only enhances efficiency but also significantly contributes to improving public health outcomes.

Individuals globally are plagued by intricate illnesses and a wide array of symptoms. Yet, they all have one crucial requirement in common: the urgent demand for the quicker creation of safer and more efficient treatments. Owkin’s goal is to enable researchers in hospitals, universities, and pharmaceutical firms to comprehend the reasons behind variations in drug effectiveness among patients, streamline the drug development process, and pinpoint the optimal medication for each individual to enhance therapeutic results. Central to Owkin's research ecosystem is Owkin Loop, which links medical researchers with high-quality datasets sourced from top academic research institutions worldwide. This innovative platform is driven by two primary elements of Owkin's Software Stack: Owkin Studio, a machine learning platform, and Owkin Connect, which serves as a federated learning framework. Additionally, Owkin is actively engaged in medical research collaborations across various fields, including Oncology, Immunology, and Cardiovascular diseases, showcasing the breadth of its commitment to improving patient care. Their collaborative efforts reflect a dedication to transforming healthcare through advanced technology and data-driven insights.

AIDDISON™ is an innovative drug discovery software that harnesses the capabilities of artificial intelligence (AI), machine learning (ML), and advanced 3D computer-aided drug design (CADD) techniques, serving as an essential resource for medicinal chemistry applications. This comprehensive platform streamlines both ligand-based and structure-based drug design, effectively merging all components necessary for virtual screening while also facilitating in-silico lead discovery and optimization processes. By leveraging these cutting-edge technologies, AIDDISON™ significantly enhances the efficiency and effectiveness of the drug development pipeline.

Our software products are crafted for simplicity and quick comprehension. User-friendly interfaces, developed in collaboration with Oncologists, are designed to maximize efficiency and save valuable time. We implement robust systems aimed at improving patient safety while introducing innovative modules that push the boundaries of research. Automation is at the heart of our solutions, facilitating everything from chemotherapy order planning to staff management. We provide a thorough solution tailored for cancer centers, optimizing the Oncology workflow seamlessly. With our platform, generating accurate chemotherapy orders is a swift and uncomplicated process. Our extensive protocol library boasts over 1000 regularly updated protocols. The system automatically calculates and confirms drug doses and infusion rates while being rigorously tested and CE marked for quality assurance. All doses are verified twice, and checks for drug-drug and drug-allergy interactions are included. Patient-drug matching is enhanced through QR coded labels, significantly reducing medication errors. Users can conveniently view the active chemotherapy order, patient diagnosis and stage, the latest lab results, and the chemotherapy flowsheet all on a single screen, ensuring a comprehensive overview at a glance. This streamlined approach promotes efficiency and safety in Oncology practice.

DentalRx offers a free clinical resource to dentists and dental students. Download the app to get up-to date dental guidelines, drug information and clinical support. DentalRx helps dentists make informed, safe and efficient decisions about prescribing medications or creating treatment plans. DentalRx, a new app designed specifically for dentists and developed in collaboration with Canadian professors of dentistry, provides access to essential tools such as dental drug monographs and dose calculators. It also includes clinical guidelines and safety guidelines to ensure accurate treatment planning and safe prescribing. Join the thousands of dental professionals who already use DentalRx to elevate clinical practice and improve patient outcomes. Start using DentalRx today and enjoy a faster, more efficient, and safer way to practice clinical dental care. Download DentalRx now!

DxScript® is a cloud-based ePrescribing solution that is certified by Surescripts™ and EPCS, ensuring compliance with HIPAA regulations while providing instant access to insurance, pharmacy benefit eligibility, and formulary data at the time of prescribing. We host a comprehensive database that includes the most recent medications released by the FDA and DEA, along with a listing of all pharmacies equipped for EDI or eFax services. Our electronic PDR offers real-time alerts for drug-to-drug interactions, potential allergies, and food contraindications right at the care point. In cases where a contraindication or allergy is detected, DxScript® proactively recommends alternative medications. The system does not necessitate any proprietary hardware or software, and all setup and training are conducted by our expert Customer Care Engineers at no charge to providers. Additionally, it allows seamless access to pertinent clinical information for any patient from a third-party EHR/PMS system, enhancing the overall efficiency of the prescribing process. For further details, consider downloading the Integration Engine Overview.

MDToolbox-Rx is a renowned electronic prescription writing solution that is both certified and award-winning, capable of operating independently or in conjunction with your existing office software. This e-prescribing platform is designed to be highly customizable and user-friendly, enabling users to effortlessly choose medications, access drug information, and swiftly create and transmit prescriptions electronically. Certified for e-Prescribing, Eligibility verification, Formulary checks, EPCS (e-Prescribing of Controlled Substances), and Electronic Prior Authorization, MDToolbox-Rx ensures a comprehensive approach to medication management. Users can search an extensive drug database by various criteria, including name, nickname, generic or brand classification, prescription status, over-the-counter status, drug class, or medical indication. By streamlining workflows, this software significantly boosts productivity by reducing the number of pharmacy calls and minimizing the time required for prescription renewals. Overall, MDToolbox-Rx enhances the efficiency of the prescribing process, making it an essential tool for healthcare providers.

A standardized procedure for the management of investigational agents is essential to enhance patient safety while ensuring adherence to regulatory requirements. This process includes implementing safeguards to avoid the selection of expired or quarantined agents during dispensing, thereby reducing the chance of providing medication to patients not participating in a study. It is crucial to meticulously capture all dispensing details and document them in the Drug Accountability Record Form (DARF). Additionally, measures should be taken to prevent the distribution of drugs that may expire within the treatment period by thoroughly assessing the dispense date, available supply, and expiration date. Tracking details such as drug thaw time, reconstitution time, and temperature readings at the time of reconstitution is also vital. The centralized electronic management of investigational agents enhances clarity, minimizes paperwork and handwriting errors, and simplifies inventory management, allowing pharmacists to dedicate more time to critical tasks and patient care. Furthermore, while DARFs can be tailored using various filters, they still maintain a uniform appearance across all protocols, regardless of the sponsor involved, ensuring consistency and ease of use for all parties. This comprehensive approach to managing investigational agents ultimately contributes to a safer and more efficient clinical trial environment.

The iMed e-Rx electronic prescription platform is available starting at $43 per month, allowing users to generate both legend and EPCS compliant prescriptions, and it holds certification for e-Prescribing across all states. In addition to its electronic prior authorization and formulary support features, the software offers significant advantages such as checks for drug-drug interactions, allergies, and disease interactions. Other noteworthy features include a regularly updated database of pharmacies, drug therapy monitoring capabilities, and continuous 24/7 oversight of prescription deliveries, ensuring a comprehensive solution for healthcare providers. With these capabilities, iMed e-Rx stands out as a robust tool for efficient and safe prescribing practices.

We facilitate the transition to value-based healthcare by evaluating various treatments, medications, processes, and costs, which aids hospitals, life sciences firms, and payers in pinpointing the most effective treatment strategies for optimal patient results. Our CRCA™ P&T platform equips Pharmacy and Therapeutics committees to implement data-driven enhancements in key quality indicators, including metrics like average length of stay (ALOS) and 30-day readmissions. The innovative POP-BUILDER Rx™ solution offers comparative evaluations among chosen cohorts against CRCA’s extensive real-world data index, which encompasses over 140 million longitudinal patient records. Additionally, our drug remittance dashboard provides an in-depth analysis and reporting of drug remittance information across different payer categories, focusing on high-cost medications at the National Drug Code (NDC) level. Furthermore, we assist hospital finance teams in effectively tracking and enhancing service line costs and profitability, productivity, and revenue cycle performance through our insightful analytics, detailed reporting, and the expertise of our Agilum Healthcare Intelligence team. This comprehensive approach ensures that healthcare providers can make informed decisions that positively impact both operational efficiency and patient care.

BIOiSIMTM represents a groundbreaking 'virtual drug development engine' that significantly enhances the drug development sector by effectively identifying drug compounds that are most likely to provide meaningful therapeutic benefits for various diseases or conditions. We provide an array of translational solutions that are tailored to meet the specific needs of your pre-clinical and clinical initiatives. Central to our offerings is the highly validated BIOiSIMTM platform, which supports the development of small molecules, large molecules, and viruses. This innovative platform is underpinned by extensive data derived from thousands of compounds across seven different species, resulting in a level of robustness that is uncommon in the field. Emphasizing human health outcomes, the heart of the platform features a translatability engine that seamlessly converts insights gained from different species. Importantly, the BIOiSIMTM platform can be deployed prior to the initiation of preclinical animal trials, facilitating earlier insights and potentially reducing the costs associated with outsourced experimentation. By integrating these advanced capabilities, we aim to streamline the drug development process and accelerate the journey from discovery to market.

Our comprehensive suite of products links clinics and physicians to the necessary pharmacies and laboratories for effective treatment delivery. The offerings 1to1Clinic, 1to1MD, and 1to1Pharmacy are designed to be fully mobile-compatible and adhere to HIPAA standards, enabling your practice to offer online medical services, electronic diagnoses, e-prescriptions, and more at any hour of the day throughout the year. This innovative medical software provides the results that both you and your patients seek and deserve. With features that enhance mobile collaboration, patient outreach, and engagement strategies for clinicians, doctors, and pharmacists alike, EhealthGlobal equips you with user-friendly tools essential for secure communication, accurate diagnosis, and effective treatment administration. Additionally, this platform ensures that all interactions occur within a completely secure environment, reinforcing trust and reliability in patient care.

PharmCare SaaS provides a community pharmacy solution with patient record / drug review management, prescription management, stock management and dispensing / drug label management. It supports multi-branches / outlets as well as multi-languages and Drug Icon CC support.

Accessible on Android, desktop, or via the web, our platform empowers you to enhance your practice through cutting-edge automated pharmaceutical care solutions. Quickly document and access patient medication histories, ensuring compliance with pharmacy record-keeping regulations while minimizing the risk of penalties. Improve your patient relationships by staying informed and attentive to their needs. Automatically send SMS reminders for medication refills to keep patients engaged, and effectively reach segmented patient demographics with targeted bulk messages. Foster loyalty by enabling responses to SMS communications, and check for over 14,000 potential drug interactions to safeguard patient health. Efficiently manage refills for chronic medications while tracking usage statistics and receiving regular updates on your operational metrics. Seamlessly integrate with your Quickbooks inventory or POS system, and create a dedicated online webpage to attract new patients. Additionally, receive support in delivering routine primary care and provide tailored drug information that adheres to international best practices, ensuring that your pharmaceutical care is not only effective but also personalized. This comprehensive approach positions you to excel in patient care and operational efficiency.

At Genospace, we recognize that the evolution of precision medicine is being propelled by advancements in genomics, yet the challenge of effectively scaling its implementation remains unresolved. Our mission is to bridge this gap. Our innovative platform aims to transform biomedical data into valuable insights that are easily accessible for all, particularly for those actively involved in delivering care. Equip your clinicians and researchers with essential information that empowers them to make well-informed choices while participating in our goal of utilizing intricate molecular data to enhance patient outcomes and speed up the processes of drug development and research. In this context, the significance of large-scale population data for drug discovery and research cannot be overstated. Utilize cohort-driven analyses through the Genospace platform to support your research initiatives. We have a strong focus on clinical trial research, enabling the Genospace platform to seamlessly align fragmented patient information with intricate trial requirements, thus facilitating quicker patient recruitment. Furthermore, our platform is designed to integrate genomic medicine into standard clinical care practices, making it easier than ever to harness the power of genomics in everyday healthcare. Together, we can push the boundaries of what’s possible in patient care and research.

Enhance the effectiveness of antimicrobial use in hospitals by equipping prescribers and Antimicrobial Stewardship Program (ASP) members with our innovative AI-driven software, ZEVAC. The challenge of antibiotic resistance represents a critical public health concern today. ZEVAC is an advanced AMS software harnessing the power of AI to assist hospitals in eliminating unnecessary or improper antibiotic prescriptions. It employs a scientific yet unconventional methodology in combating the rise of antimicrobial resistance (AMR). By utilizing ZEVAC, clinicians can access precise and tailored antibiotic susceptibility predictions, which are informed by patient demographics, clinical details, local hospital prevalence, susceptibility trends, and historical culture data. In addition, ZEVAC empowers ASP members by providing proactive strategies to prevent inappropriate antimicrobial use through its real-time analysis of comprehensive hospital clinical data, ultimately fostering a more responsible approach to antibiotic stewardship. This multifaceted approach not only aids in individual patient care but also contributes to the broader goal of preserving antibiotic efficacy for future generations.

DrugCard is an AI-powered pharmacovigilance platform designed to help pharmaceutical companies, CROs, and drug safety teams automate routine PV processes and manage safety information more efficiently. The platform brings together global and local literature monitoring, regulatory intelligence, and adverse event management in one connected workflow. DrugCard supports PV teams in identifying relevant safety information faster, reducing manual screening workload, and maintaining transparent, audit-ready processes. Its literature monitoring module covers 121+ countries, 2,200+ local medical sources, and 100+ languages, including both global databases such as PubMed and local, non-indexed medical journals. The platform uses AI to support article pre-assessment, generate structured summaries, highlight relevant keywords, assist with translations, and help users prioritize publications that may require safety review. DrugCard also provides configurable workflows, automated notifications, reporting tools, QC functionality, audit trails, and case creation from literature. With additional modules for Regulatory Intelligence and Adverse Event Database management, DrugCard helps organizations track health authority updates, centralize safety data, support E2B workflows, and improve overall pharmacovigilance operations. Built for MAHs, QPPVs, LQPPVs, CROs, regulatory teams, and PV professionals, DrugCard combines automation with human expert oversight to support compliant, scalable, and reliable drug safety management.

The innovative IWRS facilitates a streamlined and organized drug distribution across various investigation sites, significantly minimizing drug wastage while also adeptly managing intricate randomization processes for both single-arm and extensive multi-arm, multi-center studies. Additionally, the SyMetric Platform's Dynamic Adaptive Randomization feature prevents covariate imbalances among participants, ensuring equitable Treatment Assignment regardless of the sample sizes involved. With the patient management capabilities on the SyMetric Platform, users can efficiently handle Subject Screening and Enrollment, manage Visits, dispense and receive Investigational Product (IP), execute Unblinding, and oversee Withdrawals and Completion processes. Moreover, the robust IP supply management tools embedded in the SyMetric Platform empower drug supply coordinators to maintain stringent control over the supplies dispatched to sites, allowing them to modify supply strategies based on the current treatment arms and updated ratios. This comprehensive approach not only enhances operational efficiency but also strengthens the integrity of clinical trial outcomes.

Our worldwide data-sharing network produces actionable clinical insights from data aimed at enhancing patient outcomes on a global scale. SOPHiA GENETICS is dedicated to shaping the future of AI-enhanced medicine. By integrating various healthcare-omics data types, we are dismantling existing data barriers and creating machine learning models that yield insights capable of aiding healthcare professionals in elevating patient care. The updated interface, along with new features and advanced functionalities, will further expedite precision medicine workflows, bringing us closer to making data-driven healthcare accessible to all. Utilizing the power of AI and machine learning (ML), our cloud-based platform offers a secure and easily accessible space for the standardization, computation, and analysis of digital health data, which generates insights from intricate multimodal data sets that can significantly enhance diagnostic processes, therapy choices, analytical methods, and drug development initiatives. Moreover, our continuous evolution reflects our commitment to innovation in the healthcare sector.

Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.

The mobile EMR transforms points of care for hospitals. A mobile-based EMR app that connects with your existing EMR, HIS, and transforms pointof care. It saves time and allows nurses and doctors to access their patient EMR from anywhere and anytime, online or offline. App usability is enhanced by user-centric imagery and content.

PharmaPendium serves as a robust platform that grants users access to a wide array of FDA and EMA drug approval documents, encompassing essential aspects like pharmacokinetics, pharmacodynamics, and safety evaluations. This resource delivers in-depth insights into drug-drug interactions, side effects, and outcomes from clinical studies, thereby empowering stakeholders to make well-informed decisions during the drug development process and when making regulatory submissions. Its rich database aids researchers and healthcare practitioners in assessing both the efficacy and safety of medications, playing a pivotal role in the progression of pharmaceutical research and enhancing patient care. Users can explore historical regulatory submissions and leverage past precedents to better understand and anticipate agency requirements. The interface allows for a seamless transition from tabular data to dynamic charts, graphs, and other visual tools, making it easier to analyze and interpret findings. Additionally, users can search for information related to adverse events (MedDRA), therapeutic targets, drug indications, and endpoints utilizing standardized data. Result pages effectively connect preclinical research with clinical applications, facilitating a comprehensive understanding of the drug development landscape. Overall, this platform not only streamlines the research process but also fosters collaboration and knowledge-sharing among industry professionals.

The diversion of controlled substances can occur at any point within the pharmaceutical supply chain, with a significant prevalence in hospital pharmacies and healthcare settings. HelioMetrics Healthcare Rx Drug Diversion Analytics Software is designed to enhance the detection of drug diversion activities, streamline investigations, and minimize the financial repercussions associated with such diversions in the healthcare sector. Headlines frequently highlight the ongoing "opioid epidemic," showcasing widespread issues of healthcare professionals and pharmacists misappropriating these and other medications. In extreme instances, the actions of some healthcare workers have led to serious public health threats, including concerns regarding HIV and Hepatitis C transmission. Numerous cases have escalated into legal disputes, resulting in hospitals facing extensive lawsuits from former patients affected by this situation. Additionally, the consequences are compounded by significant fines imposed by the DEA, underscoring the gravity of the situation. The dangers posed by drug diversion extend beyond patient safety, presenting substantial financial challenges for healthcare organizations and necessitating immediate attention and action.

DynaMedex merges the clinical acumen and meticulously curated disease information from DynaMed with the thorough overview of treatment options, expansive drug data, and AI-driven search functionalities of Micromedex. It equips users with evidence-based insights that facilitate superior clinical decision-making and enhance patient outcomes. Clinicians utilizing DynaMedex can effortlessly search, browse, and stay updated on the topics and specialties that are most relevant to their practice, receiving both quick responses and comprehensive insights into their drug inquiries. Delve into this innovative tool and discover how it fosters improved clinical decision-making. Users can swiftly obtain answers to their drug-related questions through intuitive and conversational search features. The "Ask Watson" assistant employs artificial intelligence to streamline access to drug information, eliminating the need for traditional keyword searches in favor of natural language queries, allowing users to communicate in their own words and receive the information they seek efficiently. This seamless integration of AI technology not only saves time but also empowers healthcare professionals to make informed decisions with greater ease.

At PathAI, we are dedicated to enhancing patient outcomes through trustworthy AI-driven technology and meaningful partnerships, with the goal of delivering the most precise diagnoses and effective treatments to patients. Our innovative translational platform, supported by our skilled team of scientists, biostatisticians, and machine learning experts, uncovers and examines new cellular and tissue patterns to identify pathology-related features that yield groundbreaking insights throughout all stages of drug development and various therapeutic domains. By employing dependable and consistent technology, our platforms aim to reduce observer variability and enhance patient selection and stratification, ensuring that the most suitable patients are included in each trial, thereby boosting the likelihood of successful outcomes. Additionally, our technology establishes the most accurate cut points, allowing us to enhance precision and maximize the number of patients who test positive for biomarkers, ultimately contributing to more effective treatments. This commitment to excellence positions us at the forefront of transforming healthcare through advanced analytics and collaboration.

PEPID has been providing web-based point of care solutions for healthcare professionals for more than 20 years. These solutions allow them to accurately dose patients and diagnose medical conditions, as well as detect drug interactions and allergic reactions. PEPID products are integrated into the systems of hospitals, universities, schools, and clinics around the globe. PEPID simplifies medical information with a built-in workflow that was developed over years of interaction with pharmacists, doctors, and nurses. This unmatched organization allows healthcare professionals to have faster access and better clinical performance. It also gives them greater mobility. PEPID is used by schools to improve learning in the classroom, clinical, or study setting. PEPID is a better risk management system, greater productivity, and higher staff and patient satisfaction.

Empower your pharmacy team to make precise and beneficial medication therapy decisions, manage outpatient drug usage, and enhance adherence management through our comprehensive pharmacy solutions. Oracle Health Inpatient Pharmacy is crucial for ensuring that medications are administered safely and efficiently during a patient's care journey. By utilizing Inpatient Pharmacy medication management, your pharmacy and clinical staff can streamline their workflows to ensure patients receive the correct medication promptly. The innovative software solutions and databases developed by Multum provide essential drug information, enabling clinicians to make safe medication recommendations with the correct dosage while effectively managing drug interactions. Additionally, these solutions offer extensive access to patient clinical data, facilitate seamless information sharing among caregivers, and provide alerts for continuous patient monitoring. Furthermore, they include tools designed to improve pharmacy operations and enhance overall departmental workflows, ultimately contributing to better patient outcomes and satisfaction.

75Health is an innovative electronic health record (EHR) platform hosted in the cloud, designed to assist healthcare providers in small to medium-sized clinics with the organization and management of patient data and digital files. Its primary functionalities encompass a comprehensive scheduler, medication list tracking, automated email notifications, and options for monitoring diagnostic tests and vaccinations, among other tools. Healthcare professionals can conveniently upload and keep patient records and various practice documents, such as consent forms, educational materials, and imaging results. The platform also allows users to digitize information related to allergies, current medications, laboratory findings, and symptom checklists while facilitating the development of tailored patient care plans that include tests and protocols. In addition to these features, 75Health supports e-prescribing, enabling healthcare workers to send electronic prescriptions and handle patient billing statements efficiently. The solution also incorporates clinical decision support, providing crucial insights into patient allergies, recommended drug dosages, and more, while also offering reminders to patients regarding overdue tests. Furthermore, 75Health ensures that users have access to assistance through multiple channels, including email and phone support, thereby enhancing the overall user experience. This comprehensive support system helps medical professionals navigate the complexities of patient care more effectively.

An online software solution that employs Quality Risk Management to systematically organize, evaluate, and link Quality data directly to the particular risks associated with patients and pharmaceutical products. Why Choose Us? CINCO is a risk-oriented quality management platform tailored for the Life Sciences sector, offering a paperless method of tracking every critical quality component of a drug or medical device, thus facilitating informed quality decisions at all times. The Importance of Risk Management: Quality Risk Management is a systematic approach that ensures the identification and mitigation of potential risks throughout the manufacturing processes of drugs and medical devices, a method now mandated by most regulatory bodies. Despite its necessity, the traditional paper-based systems prevalent in the Life Sciences Industry fail to effectively handle the wealth of crucial risk information, leading to errors, excessive user friction, and ultimately diminishing operational value. Accessing essential product quality information on demand is vital for enhancing decision-making processes and ensuring safety. By transitioning to a digital system, organizations can streamline their risk management practices and improve overall product integrity.

Rare diseases often lack comprehensive research, resulting in insufficient knowledge about essential elements for an effective drug discovery initiative. Our innovative AI platform, Healnet, addresses these issues by scrutinizing vast amounts of drug and disease data to uncover new connections that may lead to potential treatments. Utilizing cutting-edge technologies throughout the discovery and development process allows us to operate multiple phases simultaneously and on a large scale. The conventional approach of focusing on a single disease, target, and drug is overly simplistic, yet it remains the standard for most pharmaceutical companies. The future of drug discovery is driven by AI, characterized by parallel processes and an absence of rigid hypotheses, fundamentally integrating the three core paradigms of drug discovery into a cohesive strategy. This new paradigm not only enhances efficiency but also fosters creativity in developing solutions for complex health challenges.

Each day, countless individuals seek care at hospitals or clinics, united by a common goal: enhancing their quality of life. However, historically, few healthcare professionals have monitored the long-term outcomes after patients leave their care. At Heartbeat, we assert that when healthcare providers engage in follow-up with patients, it leads to mutual advantages. Clinicians gain insights into which treatments yield the best results, while patients tend to experience improved health and even extended longevity by actively participating in their care journey. Patient-Reported Outcome Measures (PROMs) consist of standardized and validated questionnaires that patients fill out to assess their functional well-being and overall health status. In essence, these measures allow patients to communicate directly with their doctors about the effectiveness of specific surgeries, medications, or interventions they have received, thereby enriching the healthcare experience for all involved. This feedback loop is vital for refining treatment approaches and ensuring that patient voices are heard in the decision-making process.

Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.

Discard your prescription pad, as iPrescribe allows you to conveniently prescribe any medication right from your mobile device. This app offers a more secure and quicker alternative to traditional prescribing methods while you’re away from your practice. It provides you with access to vital information such as your patients' medication history, state PDMPs, and clinical alerts, among other features. Our reliable process simplifies the steps involved in selecting a medication, drafting a prescription, signing it, and sending it off. To expedite your workflow, we highlight frequently prescribed drugs and popular medications. By leveraging a vast network of patient-prescriber relationships, iPrescribe can often seamlessly import your current patients during the signup process. Additionally, we perform a comprehensive check to enhance your experience. iPrescribe retrieves a patient’s medication history through Surescripts, the leading e-prescribing network in the U.S., as well as other exclusive sources at DrFirst, ensuring you have access to the most thorough history available. Simply click the Med History button found in a patient’s profile to get started on a more efficient prescribing journey. This innovative approach transforms how healthcare providers manage prescriptions on the go.

Efficiently oversee every facet of your specialty drug stock through an intuitive and adaptable platform that offers beneficial ordering functionalities. By minimizing waste, removing uncertainty, and conserving valuable time, this cloud-based inventory management system is tailored to accommodate the brisk pace of your practice. With Inventory Management Solutions, you can optimize the handling of your most significant resource, guaranteeing that essential medications are available for your patients precisely when required. Our innovative platform enhances the entire inventory management process, enabling your practice to operate with greater effectiveness. Simplifying everyday tasks such as monitoring drug acquisitions, administering medications, and managing restocking ensures that your team can prioritize patient care. The tally sheet feature allows users to input tallies directly into the system, removing the need for manual entries and automatically generating purchase orders that reflect the most cost-effective options for the recorded medications. This comprehensive approach not only boosts efficiency but also contributes to improved patient outcomes.

Utilizing a blend of advanced data mining techniques and natural language processing, CAT can efficiently pull text and specific portions from any healthcare document, identifying key components like medication names, medical procedures, diagnoses, and various disorders. With the information gathered on procedures and diagnoses, CAT is also able to formulate a Diagnosis Related Group (DRG) or an Emergency Medical Service (EMS) level. Additionally, CAT assesses the document against various PQRS measures to ensure compliance. This technology extracts text from medical documents and swiftly transforms it into a format suitable for billing, achieving a remarkable level of accuracy. By streamlining this process, CAT enhances operational efficiencies and generates cost savings for hospitals, medical practices, and other healthcare providers that need coding services. The time spent on billing and coding sees a significant reduction, while the precision of claim submissions is greatly enhanced through this automated approach, which not only speeds up the claim processing time but also improves the overall revenue cycle for healthcare organizations. As a result, healthcare facilities experience a smoother financial operation and can focus more on patient care.

Enhance study efficiency, ensure regulatory compliance, and prioritize patient safety with Alpha Clinical Systems' electronic drug inventory management system (DIMS). By minimizing site errors and decreasing workload, you can achieve real-time transparency in your operations. The comprehensive web-based system, ez-DIMS, optimizes drug and device distributions at the site, effectively eliminating transcription mistakes. With seamless integration to ex-SourceDocx, it automatically tracks supply disbursements, offering instant visibility of the drug inventory. Transition from cumbersome and error-prone manual processes to the intuitive ez-DIMS platform. Furthermore, site workloads can be alleviated through user-friendly scanners that swiftly and accurately log study supply inventory and accountability across patient, site, and study categories. Notably, drug inventory violations at clinical sites rank as the second most frequent finding during regulatory inspections. By utilizing QC cross-checks between ez-DIMS and ez-SourceDocx, you can significantly decrease medication assignment and dispensation errors, enhancing overall compliance and safety protocols. This transformation not only supports effective management but also fosters a safer environment for patient care.

ChilliPharm allows users to upload files of any size from any location, making it easy to organize and share various types of content, including patient image libraries and training videos. The platform facilitates collaboration by enabling the sharing of resources with colleagues and team members across the globe. While medical images have significantly improved patient diagnoses, treatment, and outcomes over the years, the methods for sharing, viewing, analyzing, and securely storing these images have lagged behind technological advancements—until now. The lengthy and costly process of drug development, which can exceed a decade and billions of dollars, underscores the necessity of accelerating these efforts. Cloud computing solutions like ChilliPharm are crucial in streamlining access to vital data, benefiting not only life sciences companies but also their numerous partners in the industry. By maximizing efficiency and collaboration across teams, ChilliPharm is setting a new standard in health data management.

Assist your pharmacy team in making precise and advantageous medication therapy decisions, managing outpatient drug use, and ensuring adherence through our innovative pharmacy solutions. Oracle Health Inpatient Pharmacy is crucial in delivering medications safely and efficiently during a patient's care journey. By utilizing Inpatient Pharmacy medication management, your pharmacy and clinical staff can streamline their processes, ensuring that patients receive the appropriate medication at the optimal time. Completely integrated with our electronic health record system, Oracle Health Outpatient Pharmacy medication management provides essential tools for the efficient operation of your outpatient pharmacy. This includes collaborative clinical intelligence, decision support capabilities, drug database customization, and a comprehensive medication profile, all designed to enhance patient care and pharmacy operations. Ultimately, these solutions empower healthcare professionals to deliver high-quality services that improve patient outcomes.

Approximately two-thirds of data from the largest medication history database in the country lacks crucial sig details, potentially putting patients at a heightened risk of adverse drug reactions or worse outcomes. Fortunately, this issue can be addressed. DrFirst's SmartSigSM effectively bridges the information voids caused by absent sig data in a rapid, efficient, and precise manner. Utilizing advanced predictive data provided by SmartStrings, which identifies the most frequently prescribed drugs, SmartSig adeptly converts free text information and can even infer missing elements safely by leveraging statistics and clinical analytics for instant translation at the click of a button. This vital interoperability solution is designed for quick implementation, taking less than two hours, and works seamlessly with major electronic health records, allowing healthcare providers to dedicate more time to their patients while enhancing overall patient safety through proven methods. By streamlining the medication management process, SmartSig not only improves communication but also fosters better health outcomes.

Precision, efficiency, and assurance. The integration of generative AI into the biopharmaceutical industry is here. This technology streamlines the arduous task of gathering, organizing, and analyzing extensive data sets. Achieve essential insights with complete assurance every single time. With our AI-driven platform for data handling and validation, you will keep your workflows organized effortlessly. Collect, process, and verify your data all from a single interface. Easily search through both public and private databases using key characteristics of drugs. Categorize drugs and clinical trials based on comprehensive patient demographics. Retrieve necessary data in straightforward language. Strengthen your conclusions by linking your findings to their original sources. Direct your focus towards creating valuable outputs from your data, bypassing the tedious manual sorting process. Our advanced language models empower researchers to conduct asset evaluations 4.8 times quicker than traditional methods. We provide access to an extensive index of over 38 million scientific articles, conference papers, and clinical trial data. With this system, you’ll have all the information you require at your fingertips, ensuring timely and informed decision-making. Additionally, our platform adapts to your unique needs, enhancing the research experience even further.

Posos, a leading AI clinical-decision-support solution, helps clinicians customize every prescription to the patient profile using up-to date and multi-sources of medical data. Posos reduces the workload of providers while improving patient safety. It does this by comparing evidence-based data with EHR data to identify iatrogenic risk and reduce over-alerting. It offers potential drug substitutions that minimize side effects for the same or similar conditions. Posos API modules can be seamlessly incorporated into EHR software or ePrescription software. It has been successfully embedded in 15 EHRs and EMRs. It is based on the first native SNOMED-structured multilingual medical database.